Jury picked for US trial of Mexican drug lord El Chapo

Remigio Civitarese
Novembre 9, 2018

The pool of potential jurors for the USA drug trafficking trial of accused Mexican drug lord Joaquin "El Chapo" Guzman continued to shrink on Tuesday, with two people who expressed fears about their safety and one self-described "fan" of the defendant cut from the running.

Guzman formerly led the Sinaloa Cartel, based in the Mexican state of Sinaloa, which became one of the most powerful drug trafficking organizations in the world.

His notoriety has prompted security measures that include keeping the jurors anonymous. Guzman also has been held in solitary confinement and barred from seeing his wife Emma Coronel Aispuro out of concerns he could pass messages to his cohorts.

On Wednesday, Guzman was awaiting for word on whether he can hug his wife for the first time in almost two years.

Allowing "an embrace with the railing between them would not pose a threat to security", the letter read.

The judge has not ruled on that. According to official court documents, "The only human contact Mr. Guzman has had since his extradition has been with the jail personnel when putting and removing his shackles, and a quick handshake from his attorneys when he goes to court".

One of the people dismissed on Tuesday after expressing fear about the case said she had come across news reports that Guzman promised not to kill jurors, which made her "pretty anxious".

The 12 include at least three immigrants and three who speak Spanish fluently.

The man, whose identity is withheld along with all potential jurors under the rigorous security arrangements surrounding the trial, was born in Colombia but has spent the last 20 years living in NY.

One young woman said that her mother had told her "we've got to move and get a new house".

The woman was kept on after defence attorney Jeffrey Lichtman argued that dismissing her would set the precedent that jurors could get out service "with a few tears".

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE